Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Rebecca G. Smith(University of Exeter), Katie Lunnon(University of Exeter), Laura Winchester(University of Oxford), Stephanie J. B. Vos(Maastricht University), Johannes Streffer(University of Antwerp), Jennifer Imm(University of Exeter), Julius Popp(University Hospital of Lausanne), Philip Scheltens(Amsterdam Neuroscience), Pieter Jelle Visser, Sebastiaan Engelborghs(University of Antwerp), Miren Altuna(Fundacion CITA Alzheimer), Alejo Nevado‐Holgado(University of Oxford), Isabel Sala(Biomedical Research Networking Center on Neurodegenerative Diseases), Morteza Kouhsar(University of Exeter), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Ellen De Roeck(University of Antwerp), Ulf Andréasson(University of Gothenburg), Magda Tsolaki(AHEPA University Hospital), Jill Richardson(GlaxoSmithKline (United Kingdom)), Ehsan Pishva(University of Exeter), Rik Vandenberghe(KU Leuven), Valerija Dobričić(University of Lübeck), Charlotte E. Teunissen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Kaj Blennow(University of Science and Technology of China), Régis Bordet(Université de Lille), Jolien Schaeverbeke(KU Leuven), Mikel Tainta(University of London), Yvonne Freund‐Levi(Karolinska Institutet), Michael Wittig(Christian-Albrechts-Universität zu Kiel), Lars Bertram(University of Lübeck), Frans Verhey(Maastricht University), Giovanni B. Frisoni(University of Geneva), Olivier Blin(Aix-Marseille Université), Gwendoline Peyratout(University Hospital of Lausanne), Simon Lovestone(Warneford Hospital), Lutz Frölich(Heidelberg University), Andre Franke(Christian-Albrechts-Universität zu Kiel), Peter Johannsen(Rigshospitalet), Henrik Zetterberg(University of Gothenburg), Alberto Lleó(Hospital de Sant Pau)
Cited by 16
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|568
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554